Molecular modeling of the human vasopressin V2 receptor/agonist complex
暂无分享,去创建一个
Cezary Czaplewski | Rajmund Kazmierkiewicz | Jerzy Ciarkowski | C. Czaplewski | R. Kazmierkiewicz | J. Ciarkowski
[1] E. Kojro,et al. Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor* , 1996, The Journal of Biological Chemistry.
[2] A. Scheer,et al. Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.
[3] C. Levinthal,et al. Predicting antibody hypervariable loop conformation. I. Ensembles of random conformations for ringlike structures , 1987, Biopolymers.
[4] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[5] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[6] F Guarnieri,et al. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Experimental analysis and energy minimization of the complex between TRH and TRH receptor. , 1996, Biochemistry.
[7] C. Strader,et al. Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.
[8] R Henderson,et al. Electron-crystallographic refinement of the structure of bacteriorhodopsin. , 1996, Journal of molecular biology.
[9] G. Flouret,et al. Neurohypophyseal hormone-responsive renal adenylate cyclase. II. Relationship between hormonal occupancy of neurohypophyseal hormone receptor sites and adenylate cyclase activation. , 1978, The Journal of biological chemistry.
[10] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[11] Gebhard F. X. Schertler,et al. Projection structure of rhodopsin , 1993, Nature.
[12] T. Sugimoto,et al. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. , 1994, The Journal of biological chemistry.
[13] S. H. Buck. The Tachykinin Receptors , 1994, The Receptors.
[14] T R Stouch,et al. Three-dimensional quantitative structure-activity relationships of sulfonamide endothelin inhibitors. , 1995, Journal of medicinal chemistry.
[15] T. Blundell,et al. Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. , 1988, Science.
[16] P Herzyk,et al. Automated method for modeling seven-helix transmembrane receptors from experimental data. , 1995, Biophysical journal.
[17] K Prendergast,et al. Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. , 1994, Chemistry & biology.
[18] X. Bertagna,et al. Cloning and characterization of the human V3 pituitary vasopressin receptor , 1994, FEBS letters.
[19] J. Wess,et al. Different Single Receptor Domains Determine the Distinct G Protein Coupling Profiles of Members of the Vasopressin Receptor Family (*) , 1996, The Journal of Biological Chemistry.
[20] F. Fahrenholz,et al. An extracellular residue determines the agonist specificity of V2 vasopressin receptors , 1995, FEBS letters.
[21] J. Shine,et al. Protein-coupled Receptors , 1996 .
[22] J Hoflack,et al. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. , 1995, The EMBO journal.
[23] E. Kojro,et al. Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. , 1993, Biochemistry.
[24] R. Henderson,et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.
[25] V. Hruby,et al. Conformational and structural considerations in oxytocin-receptor binding and biological activity. , 1990, Annual review of pharmacology and toxicology.
[26] F. László,et al. Pharmacology and clinical perspectives of vasopressin antagonists. , 1991, Pharmacological reviews.
[27] J Hoflack,et al. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.
[28] F Guarnieri,et al. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor. , 1996, Biochemistry.
[29] C. Levinthal,et al. Predicting antibody hypervariable loop conformations II: Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations , 1986, Proteins.
[30] J. Shine,et al. G protein-coupled receptors , 1992, Current Biology.
[31] J Hoflack,et al. The Binding Site of Neuropeptide Vasopressin V1a Receptor , 1995, The Journal of Biological Chemistry.